• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球、区域和国家女性非风湿性心脏瓣膜病负担:1990 - 2021年全球疾病负担的系统分析

Global, Regional, and National Burden of Non-Rheumatic Valvular Heart Diseases in Women: A Systematic Analysis of Global Burden of Disease 1990-2021.

作者信息

Chenyu Liu, Haochao Li, Pengfei Chen, Mingjian Chen, Diming Zhao, Liqing Wang

机构信息

Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College/National Center for Cardiovascular Diseases, Beijing, China.

出版信息

Glob Heart. 2025 Mar 26;20(1):33. doi: 10.5334/gh.1422. eCollection 2025.

DOI:10.5334/gh.1422
PMID:40161863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11951974/
Abstract

BACKGROUND

The incidence of non-rheumatic valvular heart diseases (NRVHD) has shown an increasing trend. However, most studies have overlooked the impact of gender on the disease. Female patients, as a specific subgroup, have rarely been discussed independently. It is essential to conduct separate epidemiological studies to understand the latest epidemiological data for female NRVHD patients and to raise awareness among researchers and clinicians.

METHODS

Data from the Global Burden of Disease (GBD) 2021 database were retrieved to obtain epidemiological data on female NRVHD from both global and regional perspectives, covering 204 countries and territories. Joinpoint regression, age-period-cohort analysis, decomposition, and predictive analyses were employed to further examine the epidemiological data.

RESULTS

The incidence of female NRVHD patients has shown a continuous upward trend and is expected to persist in the future, particularly in regions with high and high-middle Socio-Demographic Index (SDI). However, in low and lower-middle SDI regions, patients experience relatively higher Disability-Adjusted Life Years (DALYs) and Years Lived with Disability (YLDs), with a greater number of heart failure cases attributed to NRVHD. Decomposition analysis indicates that the increase in the incidence of NRVHD and its subtypes is primarily driven by population growth and aging.

CONCLUSIONS

With economic development and population aging, female NRVHD remains a significant healthcare burden for countries worldwide. Low- and middle-SDI regions should implement tertiary prevention strategies to address the impending shift in the spectrum of valvular heart diseases. Further clinical research should focus on female patients as a distinct subgroup of NRVHD, exploring the unique aspects of the disease in this population.

摘要

背景

非风湿性心脏瓣膜病(NRVHD)的发病率呈上升趋势。然而,大多数研究忽视了性别对该疾病的影响。女性患者作为一个特定亚组,很少被单独讨论。开展单独的流行病学研究对于了解女性NRVHD患者的最新流行病学数据以及提高研究人员和临床医生的认识至关重要。

方法

检索2021年全球疾病负担(GBD)数据库的数据,从全球和区域角度获取女性NRVHD的流行病学数据,覆盖204个国家和地区。采用Joinpoint回归、年龄-时期-队列分析、分解分析和预测分析进一步研究流行病学数据。

结果

女性NRVHD患者的发病率呈持续上升趋势,预计未来仍将持续,特别是在社会人口指数(SDI)高和高中等的地区。然而,在SDI低和低中等地区,患者的伤残调整生命年(DALYs)和残疾生活年(YLDs)相对较高,因NRVHD导致的心力衰竭病例更多。分解分析表明,NRVHD及其亚型发病率的增加主要由人口增长和老龄化驱动。

结论

随着经济发展和人口老龄化,女性NRVHD仍然是全球各国的重大医疗负担。低和中等SDI地区应实施三级预防策略,以应对心脏瓣膜病谱即将发生的变化。进一步的临床研究应将女性患者作为NRVHD的一个独特亚组,探索该人群中该疾病的独特方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e521/11951974/7bf746e5cc30/gh-20-1-1422-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e521/11951974/df13ae2f067f/gh-20-1-1422-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e521/11951974/838c61a4eeb8/gh-20-1-1422-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e521/11951974/16987826f5a0/gh-20-1-1422-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e521/11951974/7bf746e5cc30/gh-20-1-1422-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e521/11951974/df13ae2f067f/gh-20-1-1422-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e521/11951974/838c61a4eeb8/gh-20-1-1422-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e521/11951974/16987826f5a0/gh-20-1-1422-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e521/11951974/7bf746e5cc30/gh-20-1-1422-g4.jpg

相似文献

1
Global, Regional, and National Burden of Non-Rheumatic Valvular Heart Diseases in Women: A Systematic Analysis of Global Burden of Disease 1990-2021.全球、区域和国家女性非风湿性心脏瓣膜病负担:1990 - 2021年全球疾病负担的系统分析
Glob Heart. 2025 Mar 26;20(1):33. doi: 10.5334/gh.1422. eCollection 2025.
2
Global burden of non-rheumatic valvular heart disease in older adults (60-89 years old), 1990-2019: Systematic analysis of the Global Burden of Disease Study 2019.1990 - 2019年老年人群(60 - 89岁)非风湿性心脏瓣膜病的全球负担:全球疾病负担研究2019的系统分析
Arch Gerontol Geriatr. 2025 Mar;130:105700. doi: 10.1016/j.archger.2024.105700. Epub 2024 Nov 21.
3
Global, regional, and national incidence, mortality, and disability-adjusted life years of non-rheumatic valvular heart disease and trend analysis from 1990 to 2019: Results from the Global Burden of Disease study 2019.全球、区域和国家非风湿性瓣膜性心脏病的发病率、死亡率和伤残调整生命年,以及 1990 年至 2019 年的趋势分析:来自 2019 年全球疾病负担研究的结果。
Asian Cardiovasc Thorac Ann. 2023 Oct;31(8):706-722. doi: 10.1177/02184923231200695. Epub 2023 Sep 7.
4
Changing trends of the disease burden of non-rheumatic valvular heart disease in China from 1990 to 2019 and its predictions: Findings from global burden of disease study.1990年至2019年中国非风湿性心脏瓣膜病疾病负担的变化趋势及其预测:全球疾病负担研究的结果
Front Cardiovasc Med. 2023 Jan 19;9:912661. doi: 10.3389/fcvm.2022.912661. eCollection 2022.
5
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
6
Burden of valvular heart disease, 1990-2017: Results from the Global Burden of Disease Study 2017.瓣膜性心脏病负担,1990-2017 年:来自 2017 年全球疾病负担研究的结果。
J Glob Health. 2020 Dec;10(2):020404. doi: 10.7189/jogh.10.020404.
7
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
8
Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021.1990年至2021年全球、区域和国家瓣膜性心脏病负担
J Am Heart Assoc. 2024 Dec 17;13(24):e037991. doi: 10.1161/JAHA.124.037991. Epub 2024 Dec 14.
9
Global and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990-2017.非风湿性瓣膜性心脏病的全球和区域负担及护理质量:1990-2017 年全球疾病负担的系统分析。
Int J Qual Health Care. 2022 Apr 22;34(2). doi: 10.1093/intqhc/mzac026.
10
Global burden of bacterial skin diseases from 1990 to 2045: an analysis based on global burden disease data.1990年至2045年细菌性皮肤病的全球负担:基于全球疾病负担数据的分析
Arch Dermatol Res. 2025 Jan 16;317(1):266. doi: 10.1007/s00403-025-03804-z.

引用本文的文献

1
Global, regional, and national burden of non-rheumatic valvular heart disease and Its projections to 2035: comprehensive analysis of the global burden of disease study 2019.非风湿性心脏瓣膜病的全球、区域和国家负担及其到2035年的预测:全球疾病负担研究2019的综合分析
Front Cardiovasc Med. 2025 Aug 1;12:1445024. doi: 10.3389/fcvm.2025.1445024. eCollection 2025.

本文引用的文献

1
Global, Regional, and National Burden of Nonrheumatic Valvular Heart Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990 to 2019: Results From the Global Burden of Disease Study 2019.全球、区域和国家非风湿性瓣膜性心脏病负担及其 204 个国家和地区 1990 年至 2019 年的归因风险因素:2019 年全球疾病负担研究结果。
J Am Heart Assoc. 2024 Nov 5;13(21):e034459. doi: 10.1161/JAHA.124.034459. Epub 2024 Oct 18.
2
Global, regional, and national burden of preterm birth, 1990-2021: a systematic analysis from the global burden of disease study 2021.1990 - 2021年全球、区域和国家早产负担:全球疾病负担研究2021的系统分析
EClinicalMedicine. 2024 Sep 24;76:102840. doi: 10.1016/j.eclinm.2024.102840. eCollection 2024 Oct.
3
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.
4
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球 204 个国家和地区及 811 个亚级行政区 1990 年至 2021 年 288 种死因及预期寿命的归因分析:全球疾病负担研究 2021 系统分析。
Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3.
5
Sex Differences in Epidemiological Distribution and Outcomes of Surgical Mitral Valve Disease.外科二尖瓣疾病的流行病学分布和结局的性别差异。
Circ J. 2024 Mar 25;88(4):579-588. doi: 10.1253/circj.CJ-23-0687. Epub 2024 Jan 24.
6
Aortic Regurgitation: Review of the Diagnostic Criteria and the Management Guidelines.主动脉瓣反流:诊断标准和管理指南综述。
Curr Cardiol Rep. 2023 Oct;25(10):1373-1380. doi: 10.1007/s11886-023-01955-x. Epub 2023 Sep 16.
7
Global, Regional, and National Advances Toward the Management of Rheumatic Heart Disease Based on the Global Burden of Disease Study 2019.基于 2019 年全球疾病负担研究的风湿性心脏病管理全球、区域和国家进展。
J Am Heart Assoc. 2023 Jul 4;12(13):e028921. doi: 10.1161/JAHA.122.028921. Epub 2023 Jun 27.
8
Global and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990-2017.非风湿性瓣膜性心脏病的全球和区域负担及护理质量:1990-2017 年全球疾病负担的系统分析。
Int J Qual Health Care. 2022 Apr 22;34(2). doi: 10.1093/intqhc/mzac026.
9
Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019.204 个国家和地区 1990-2019 年缺血性心脏病负担及其可归因危险因素。
Eur J Prev Cardiol. 2022 Mar 11;29(2):420-431. doi: 10.1093/eurjpc/zwab213.
10
Valvular heart diseases in women.女性心脏瓣膜病
Egypt Heart J. 2021 Jun 26;73(1):58. doi: 10.1186/s43044-021-00184-3.